Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT03341767||Not yet recruiting||A Phase 2A Evaluation of the Safety, Tolerability, Pharmacokinetics, Efficacy of Clofazimine (CFZ) in Cryptosporidiosis||
||Other / Industry||
||66||All||18 Years to 65 Years (Adult)||NCT03341767||CFZ-001
|December 2017||December 2018||February 2019||November 14, 2017||November 14, 2017|